• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Medical Device Market
Medical Device News
Medical Device Stocks
  • Medical Device Market
  • Medical Device News
  • Medical Device Stocks
medical device investing

Alpha Pro Tech Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2017

Gabrielle Lakusta
Mar. 09, 2018 08:51AM PST
Medical Device Investing

Alpha Pro Tech (NYSE:APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the fourth quarter and year ended December 31, 2017. As quoted in the press release: Lloyd Hoffman, President and Chief Executive Officer of Alpha Pro Tech, Ltd., commented, …

Alpha Pro Tech (NYSE:APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the fourth quarter and year ended December 31, 2017.

As quoted in the press release:

Lloyd Hoffman, President and Chief Executive Officer of Alpha Pro Tech, Ltd., commented, “Our 2017 financial results were bolstered by a nearly three percentage point increase in gross profit margin, despite lower net sales. Management remains focused on strategies to manage our cost platform to maximize gross profit potential and will continue to concentrate on inventory levels across all business segments. Net income for 2017, although down, was negatively impacted by a $619,000 accrual related to the death benefit provided in the employment agreement of our former President and Chairman. Excluding this accrual, net income would have been down by only 1.2% compared to 2016, and earnings per share would actually have been $0.21 per diluted share, compared to $0.19 for 2016. Our balance sheet remains healthy, and the generation of cash from operations supports our active share repurchase program, which directly returns value to our shareholders.”

Click here to read the full press release.

inventory levels medical device investing financial results
The Conversation (0)

Go Deeper

AI Powered

Nanalysis Reports Fourth Quarter and Full Year 2021 Results

Nanalysis Reports First Quarter 2022 Results

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Medical Device Investing Stocks

Cardiex Limited

Cardiex Limited (CDX:AU)
CDX:AU

Cleo Diagnostics

Cleo Diagnostics (COV:AU)
COV:AU

Ocumetics Technology

Ocumetics Technology (OTC:CC)
OTC:CC

Avricore Health

Avricore Health (AVCR:CC)
AVCR:CC
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES